Respiratory Flashcards
Asthma definition and presentation
Chronic inflammatory airway disease. Intermittent obstruction due to hypersensitivity
Recurrent episodes: wheeze, Breathlessness, Chest tightness, Coughing
Types of Asthma
Allergic (linked to atopy - Inc IgE production)
Non-allergic
Triggers
Allergic (IgE -> Mast cell): dust mites, pet fur, grass pollen
Non-allergic: Exercise, cold air, stress, strong emotion, viral infection, smoking
Drug causes: NAIDs/Aspirin block COX1 = dec prostaglandins and inc pro-inflam leukotrienes, Beta blockers (B2)
Acute and chronic changes to airway in asthma
Acute: airway bronchoconstriction, oedema, mucus hyper secretion
Chronic: airway remodelling, hyper responsiveness
- Gives more persistent obstruction
Hygiene hypothesis
Growing up in clean env suppresses the natural development of immune system
Asthma Pathopys: Early phase (constriction phase)
Exposure to allergen in presensitised individual
cross link IgE on mast cells
Release histamine, leukotrienes, TNFa
Migration of inflammatory cells
Inc vascular permeability (airway oedema) + mucus hyper secretion, inc airway tone through smooth muscle
Asthma Pathopys: Late phase (inflammation phase)
Eosinophil mediated (IL4/5 recruits) at 6 hours
Inc goblet cells Epithelial denudation (leads to hyper responsiveness)
Deposition of matrix proteins and swelling (remodelling and SMC hyperplasia)
Asthma Presentation (when taking a Hx)
Worse at night and early morning
Wheeze Episodic SOB Chest tightness Cough FH atopy
How to assess general asthma severity/control
In the past 4 weeks
- How often SOB
- How often woken from sleep
- How often used reliever
- How often interfered with ADL (e.g. school/work)
- How do they rate asthma control
What is important to assess in asthmatic control
Inhaler technique
Asthma Investigations
Peak Expiratory Flow Rate (PEFR)
- Diurnal variation over 20%
- Reversibility testing: FEV1 improves 15% with SABA/ PEFR 20% improv
Spirometry: FEV1/FVC less than 70% + FEV1 less than 80% predicted.
FBC: Eosinophilia
Skin prick testing for allergen triggers
What is the aim of asthma management (2)
Good control on minimal meds
FEV1 and PEFR over 80% predicted
Asthma management
1 ->5
1) SABA
2) Add low ICS (400mcg budesonide)
3) Add LTRA (Montelukast)
4) Add LABA (LRTA can be kept or removed depending on response)
5) SABA + MART (Steroid+laba = can be used as maintenance AND releiver)
What are Theophylines and where do they come in on Asthma ladder?
Methylxanthine - phosphodiesterase inhibitor. inhibits leukotriene synthesis and TNFa
One of the final steps in management.
Acute asthma exacerbation management
OSHITMS
Oxygen (aim 94-98%) Salbutamol (neb) Hydrocortisone IV/Pred oral within one hour Ipratropium (neb) Theophylline (IV) Mag Sulf (IV) Salbutamol (IV)
Acute asthma exacerbation Investigations
Peak expiratory flow
SpO2
ABG
Moderate asthma exacerbation
PEF 50-75%
Severe asthma exacerbation
One of the following:
- PEF 33-50%
- RR over 25
- HR over 110
- Cant complete sentences
Life threatening asthma exacerbation
One of the following: - PEF less than 33% - SpO2 less than 92% - PaO2 less than 8kPa - Silent chest Exhaustion
May need these patients to be intubated
COPD
- Definition
- Types
Chronic & irreversible airflow obstruction giving air trapping and hyperinflation
Chronic bronchitis
Emphysema
What is Chronic Bronchitis
Narrowing of airways due to oedema of mucosa, mucous hyper secretion,
Cough due to excessive mucous and poor ciliary clearance
- Over 3M of the year for 2 yr
What is emphysema
Due to elastin breakdown causing permanent destruction and reduced SA in alveoli
Less elastin recoil/inc compliance = hyperinflation
COPD Aetiology & Pathophysiology
Cigarette smoking, A1AT
Emphysema: inc inflammation = inc neutrophils = inc oxidative stress + elastase to break down elastin in emphysema
Chronic bronchitis: Poor ciliary clearance and goblet cell hyperplasia (inc mucous)
COPD Pulmonary Pathology description
Chronic inflammation of central and peripheral airways/lung parenchyma/alveoli/vasculature
Increased goblet cells
Narrowing of airways
Vascular change = Pulm HTN
COPD Presentation
SOB - initially with exercise but this progresses
Cough
COPD examinatory findings
Barrel chest, CO2 flap, hyperresonant percussion, distant breath sounds (over bullae, hyperinflation and trapping), coarse crackles (exacerbation), wheeze (exacerbation)
COPD complications
Cor pulmonale: RHF secondary to long standing COPD (raised JVP, distended neck veins, hepatomegaly - Rx: long-term O2 therapy + loop diuretic)
Pneumonia - pneumococcal vaccine and yearly influenza vaccine
Depression
Polycythaemia
Respiratory failure (T1, T2)
Resp failure
- Types
- Reasons
- Description
Type 1 & 2
- T1 = VQ mismatch. PaO2 less than 8kPa (can get rid of CO2 but O2 not going to right place for oxygenation)
- T2 = Alveolar hypoventilation. PaO2 less than 8kPa, PaCO2 over 6kPa (large collapse, secretions blocking etc)
Pink puffer - emphysema
Blue bloater - Bronchitis
Pink puffer (emphysema)
CO2 responsive Pink skin Purse lip breathing and accessory muscle use Inc Res rate Old and cachectic
Blue bloater (Bronchitis)
CO2 retention (T2) means insensitive to it Obese Peripheral oedema (RHF)
COPD Investigations
Spirometry
- Obstructive pattern (FEV1/FVC less than 0.7)
- Non-reversible
Decreased pulse oximetry
ABG: hypoxia + hypercapnia may be seen
CXR: flattened diaphragm, increased intercostal spaces, hyper lucent lungs
FBC: may have polycythemia (HCT over 0.55 - venesection, too viscus)
Sputum culture - infectious exacerbation
COPD severity score
Mild FEV1 less than 80%
Moderate FEV1 50-80%
Severe FEV1 30-50%
V Sev less than 30%
COPD management
Patient education + Lifestyle (smoking, exercise, obesity management)
Vaccination (Pneumococcal, Flu)
Depression screen
Inhaled therapy
Long term O2 therapy (if PaO2 less than 7.3, sats less than 88% or congestive HF
COPD inhaled therapy
1) SABA or SAMA
2) If still uncontrolled
- FEV1 over 50% add LABA/LAMA
- FEV1 under 50% add LABA+ICS
3) LABA + LAMA + ICS
COPD exacerbation Tx
Similar to OSHITMS
SABA + SAMA neb (salbutamol+ipratropium)
O2 (24% venturi - aim 88-92%)
Oral Prednisolone
Airway clearance - mucolytic + physio
If respiratory insufficiency - BIPAP
Why can BIPAP be used in T2 RF
Because it doesnt have to be 100% O2.
It works more by keeping airways open rather than high O2 which can take away rest drive in T2RF patients
COPD exacerbation organisms + Investigation
H. influenza
Strep Pneumonie
Moraxella catarrhalis
Blood + Sputum culture and gram stain
Abx for COPD exacerbation
Extra therapies.
Community acquired (less severe) - amoxicillin or Doxycycline + PREDNISALONE
Hospital acquired - Vancomycin or Tazocin (piperacillin/tazobactam)
Oral Theophyline
Mucolytics (acetylcysteine)
O2 therapy
Furosemide in HF
Difference Between Asthma Vs COPD
Reversible/Irreversible
Airway hyperactivity only in asthma
Mast cells/ Eosinophils (A) Vs Neutrophils and macrophages (C)
Peak flow diurnal variation (A), minimal variation (C)
Spirometry may be ok (A) but always bad (C)
Total Lung Capacity
Tidal Volume
Expiratory reserve volume
Residual volume
6L
- 5L
- 25L
- 25L
Obstructive and restrictive effects on spirometry
Obstructive gives decrease in inspiratory reserve as tidal volume occurs at higher total volume (more air conserved)
Restrictive gives less total lung volume but also less expiratory volume moving the tidal volume at lower lung volume
Types of pneumonia
Community acquired
Hospital acquired
Pneumonia score
CRB65 (add U if in secondary care setting - can get urea)
CURB65 and how to use
Confusion
Urea (over 7)
Resp (over 30)
BP (less than 90 systolic, 60 dias)
65yrs+
0-1 low risk - outpatient
2 mod risk - hospital
3-5 high risk - ITU (15-40% 30 day mortality)
Community acquired pneumonia
- RF
- Causes
- Atypical caused
over 65, Care home, COPD (h.influena), smoking, alcohol (Klebsiella),
S.pneumonia (rusty sputum in 30%) most commonly
Mycoplasma pneumonia (different symptoms) chlamydia psitacci (Bird fanciers) Legionella pneumophilia (aircon, asco with hyponatraemia)
Hosp acquired pneumonia
Gram negative bacilli
E.coli, Klebsiealla (upper lobes), Pseudomonas aeruginosa, MRSA
Mycoplasma pneumonia (atypical - diff pres, diff, Tx)
Dry cough
Haemolytic anaemia
Erythema multiforme
Interstitial opacities (nodular) on CXR
Pneumonia
- Presentation
- Examinatory findings
Cough + Sputum
Fever (high in pneumococcal)
Bacteraemia
Arthralgia, myalgia, confusion
Inc HR, RR, temp
Dullness to percuss, crackles/reduced air entry/vocal fremitus on auscultation
If septic - low BP
Pneumonia investigations
FBC (Raised WCC)
CRP - raised
ABG - low O2x
Sputum culture and sensitivity for ABx
CXR - For lobar pneumonia to looks for consolidation. Atelectasis - small airway obstruction
Blood cultures for causative organism
Urinary antigen - legionalla, pneumococcus
Pneumonia Management
O2 if needed IV fluids if needed
Low risk: (0-1)
- Amoxicillin or macrolide (ACE: azithro, clarithro, erythro)
Mod risk: (2)
- Amoxicillin + Clarithromycin (Doxy if allergic)
High risk:
- Co-amox/3rd gen ceph + macrolide
- Co-amoxlclav + Clarithromycin
Hosp acquired:
- IV cefotaxime + Gentamicin
Legionalla:
- Clarithromycin + fluoroquinolone
Pneumonia complications
Sepsis
ARDS: non-cariogenic pulmonary oedema
TB
- Types
- RF
- Cause
- Type of infection
Pulmonary (latent, active - primary or reactivation of latent), Extra-pulmonary (military)
immunocompromised (e.g. HIV), exposure, poor nutrition, overcrowding, IVDU, homeless, prisons
M.tuberculosis, M.bovis
Granulomatous
What is a granuloma
A collection of epithelioid histiocytes (macrophages). These might also fuse to form multinucleate langerhans giant cells
TB prevention
BCG vaccine
TB screen
Tuberculin skin test (cant distinguish between active and latent disease
Latent TB
Infections with M.tuberculosis but no clinical, bacteriological or radiographic evidence of active TB
Gohn Complex
Gohn focus (Calcified focus from TB, often in mid to lower lung zones)
PLUS an affected lymph node
TB pathophysiology
Macrophage in mid zone of lung engulfs bacteria
Results in Granuloma formation, MP presentation to T-cell –> Caseation
Caseation heals and calcifies
Mediastinal LN involvement
Secondary lesions in lung apices (after 1-2 year)
TB Presentation
Cough (haemoptysis) + fever + weight loss + night sweats + RF
Pleuritic chest pain, erythema nodosum
Examination: crackles, bronchial breathing
TB investigations
CXR:
- Primary: consolidation, hilar enlargement
- healed primary: Gohn focus
Sputum acid fast (Ziehl-Neelsen) bacilli smear X3
Sputum culture shows no growths
FBC - leukocytosis and anemia
Nucleic acid amplification test +ve for TB
HIV concurrent infection possible
CT, urinalysis, Ascitic fluid analysis for extra-pulmonary TB
TB Tx
RIPE DOTS
Rifampicin - 6m (hepatotoxic, p450 inducer)
Isoniazid - 6m (hepatotoxic, peripheral neuropathy)
Pyrazinamide - 2m (liver toxic, hepatitis)
Ethambutol - 2m (optic neuritis: loss of acuity)
Directly Observed Therapy for 3 weeks
Isolate patient, contact tracing + Tx. infectivity decreased after 2w tx
Extra pulmonary TB
Pleura: effusion GU: hameaturia/dysuria Bone: osteomyelitis, Pott's - vertebral fracture assoc with TB Brain: meningitis Abdo: ascites
Miliary = haematogenous seeding. liver spleen, lung. Can be seen on CT
DVT RF
Cancer Trauma Major surgery Hopitalisation Immobilisation (including limb immobilisation and long haul travel) OCP Obesity Pregnancy (high oestrogen)
Genetics: Factor V leiden, Protein C deficiency
Protein S deficiency, antithrombin deficiency, antiphospholipid syndrome
Virchows triad
Three broad categories contributing to thrombosis:
1) Venous stasis
2) Vessel injury
3) Activation of clotting system/hypercoagulable state
Where do DVT form
Deep venous system of leg, often behind a valve
DVT marker
Active thrombus breakdown by fibrinolytic system releases cross linked fibrin breakdown products esp. D-dimer (also acute phase protein - poor specificity, more helpful if -ve)
DVT pres
Unilateral calf swelling and pain along venous system
DVT score
Wells
- Active Ca in last 6 months
- Paralysis, paresis or recent plaster immobilisation
- Recently bed ridden for 3+ days
- Localised tenderness alone deep venous system
- Entire leg swollen
- Calf swelling more than 3cm more than other
- pitting oedema
- Previous DVT
- contralateral superficial non-varicose veins
Using Wells score
0-1: D-dimer and if positive then proximal venous USS (if negative then repeat at 6 days
2+ Proximal venous USS, +ve = tx, -ve = repeat in 6-8 days
If USS not available within 4 hours then anticoagulant and do within 24 hours
PE
- Definition
- Complications
- Causes
Life threatening condition resulting from dislodged thrombi occluding pulmonary vasculature
If not Tx –> RHF and cardiac arrest
Distal vein thrombosis (50% will embolise), Amniotic fluid embolus, Fat/Air embolus, tumour embolus
PE RF (try to get 5)
Cancer Trauma Major surgery Hopitalisation Immobilisation (including limb immobilisation and long haul travel) OCP Obesity Pregnancy (high oestrogen)
Genetics: Factor V leiden, Protein C deficiency
Protein S deficiency, antithrombin deficiency, antiphospholipid syndrome
PE presentation
Chest pain (pleuritic), dyspnoea, tachypnoea, cough, fever
Large PE: shock, collapse, acute RHF, sudden death
PE signs
Tachycardia Tachypnoea Elevated JVP Hypoxia Shock (low BP)
Classical CXR PE
Wedge-shaped lesion against the pleura
PE Ddx
ACS
Aortic dissection (tearing pain - anticoagulant here fatal)
Pneumothorax
PE investigation
2 level wells DVT PE most likely cause Tachy Card Immobilisation (Surg, bed for 3 day+) Hx DVT/PE Haemoptysis Malig last 6 month
4 points = PE likely
Other: FBC, US, clotting, Trops (MI rule out), ECG, CXR (late sign = wedge), ABG (reduced PaO2, high lactate)
PE management algorithm
Well under 4 D-dimer, if +ve CTPA
If Wells over 4 CTPA immediately (if renal impair V/Q scan - contrast) if positive Tx, if negative but suspect Proximal vein USS
If CTPA not available immediately then anticoagulant until available
VTE Tx
PE: O2, IV access for fluids, Morphine
Haemodynamically stable - LMWH (dalteparin) or Fondaparinux (10a inhibitor)
Active Ca - LMWH 6m
Other people get Warfarin for 3 months then reassess (6m if unprovoked DVT)
Mechanical prevention = graduated compression stocking
Investigating cause of DVT
Cancer screen: - Physical examination, CXR, Bloods (FBC, Ca2+), Ca markers BhCG - Testis CA125 - Ovary CA19-9 - Pancreas PSA - Prostate
Thrombophila testing:
Antiphospholipid Ab
Protein C/S (deficiency)
VTE prevention
Early mobilisation and hydration post surgery
Avoid OCP
Graduated pressure stockings (TED)